Over the past decade there has been a notable increase in clinician and patient awareness of bacterial vaginosis (BV) as a frequent cause of vaginal discharge. There has also been considerable interest in the role of BV in upper genital tract infections such as pelvic inflammatory disease (PID) and preterm labour and delivery. Ironically, this prevalent and recently well studied condition remains puzzling in terms of aetiology and pathogenesis.
As the most frequent cause of vaginal discharge, BV occurs in 20-25% of the general population and in up to 50% of women attending sexually transmitted diseases (STD) clinics. Studies have shown that clinicians making empirical diagnoses without the aid of laboratory testing will frequently misdiagnose the aetiology of a vaginal infection, yet in many practices empirical diagnoses continue to be the norm. -The major symptoms associated with BV are odour and vaginal discharge. Pruritus is usually not prominent.
Bacterial vaginosis may be defined either by clinical or microbiological variables, The clinical or Amsel criteria allow for the diagnosis of BV when three of the following four criteria are met: (1) vaginal pH > 4*5, (2) positive "whiff" test when vaginal fluid is mixed with 10% KOH, (3) presence of clue cells, squamous epithelial cells covered with bacteria, and (4) presence of a homogeneous vaginal discharge.' Microbiologically, the syndrome of BV is defined by a shift in vaginal microbes away from a lactobacillus predominant flora to a vaginal milieu in which there are greatly increased numbers of bacteria consisting mainly of anaerobes and facultative anaerobes (Gardnerella, mycoplasmas, Prevotella/Porphyromonas, Mobiluncus) and diminished numbers of lactobacilli, especially those that produce hydrogen peroxide. These shifts in flora can be demonstrated by Gram stain and a standardised method of determining the presence of BV by Gram stain has been developed, the Nugent method.2 Shifts in the bacterial flora can also be appreciated by closely examining the bacteria on the saline wet mount. In patients with BV, the large rods consistent with lactobacilli will be absent and replaced by large numbers of coccobacilli and perhaps motile, curved rods (Mobiluncus). Comparison of the Amsel and Nugent criteria has shown that the Nugent criteria have a sensitivity of 89% compared with the Amsel criteria but a specificity of 83%. The latter raises questions about the true sensitivity of the Amsel criteria and suggests that perhaps the Gram stain should be considered the gold standard. 3 The aetiology of BV remains unknown. In fact, the most basic of questions regarding its pathogenesis remain unanswered. For example, is it the result of bacterial overgrowth or is it a transmissible infection? If it is an over- Of 26 subjects, only four women had lactobacillus, the predominant flora throughout the study. Symptoms were intermittently reported by the women in this study, but the presence of symptoms did not correlate with microbiological changes as detected on Gram stain. We have also examined normal volunteers, examining daily self obtained Gram stains.5 Our findings concur with those of Priestley et al, in that we found two distinct vaginal flora patterns-one in which only lactobacilli are present throughout the month and the other in which these lactobacillus predominant days are interspersed with days having moderate to large numbers of GardnerellalBacteroides morphotypes. The greatest period of variability in these patients occurred at the time of the menses. It is interesting to hypothesise that women with this "unstable" vaginal flora pattern may be at greater risk of developing persistent changes-that is, BV.
Thus far, it is not known why some women have such shifts in their vaginal flora. Priestley et al's study was unable to determine an association between external factors and changes in the vaginal flora, although they did not examine the role of vaginal douching which has been suggested as having an influence in the pathogenesis of this syndrome. Perhaps the difference between these two groups of women is related to the behaviour of their sexual partners instead of their own. In many ways, BV behaves as if it were an STD. Epidemiologically, BV occurs primarily in sexually active women who have had multiple sexual partners or a recent new partner and it is frequently a coinfection with other STDs. Bacteria associated with BV have been cultured from the male genital tract, particularly among partners of women with BV. In this issue of Genitourinary Medicine, Keane et al (p 373) describe their results from a study of sexual partners which examined the association between abnormal vaginal flora in the female and non-gonococcal urethritis (NGU) in the male. The investigators found a significant correlation between the presence of NGU and abnormal vaginal flora which was even stronger when only men without evidence of chlamydial infection were analysed. Although the authors concede that their findings may have been influenced by their inability to study the partners of all the index cases enrolled, this study provides interesting preliminary data concerning a possible aetiology for a non-gonococcal, non-chlamydial urethritis.
A follow up study with a large number of patients as well as more sensitive detection techniques for chlamydia and trichomoniasis should be performed. Of interest is that we have found a similar association between abnormal vaginal flora and non-gonococcal, non-chlamydial cervicitis in women, discussed below. 10 Although prospective studies are needed to confirm these observations, data such as these suggest that treatment of BV, whether symptomatic or asymptomatic, with re-establishment of the normal vaginal flora, may be an important adjunctive means of controllings STDs.
Data continue to accumulate on the complications associated with BV. Studies have documented the ability of BV related organisms to ascend into the upper genital tract in both the pregnant and non-pregnant patient." 12 The epidemiological association between BV and preterm delivery has been well documented by-numerous investigators. For the pregnant patient, studies designed to determine if the treatment of BV will prevent preterm labour and delivery are ongoing with a definitive conclusion yet to be reached. In a study of Hauth et al, treatment with erythromycin and metronidazole decreased the outcome of preterm labour among women deemed to be at risk for this event, especially among those women with BV.13 Although it provides important data, the design of this study-that is, two drugs and a select population, does not provide us with guidelines for the general population. Beyond this initial question of whether treatment of BV in pregnancy will prevent preterm delivery, are issues dealing with the appropriate diagnostic test to use in this setting, the antibiotic regimen of choice, the timing of therapy, and the necessity of a "test of cure." In the non-pregnant patient, parallel questions regarding treatment of BV as a means to prevent PID will be far more difficult to answer.
Preliminary data have also implicated BV in the pathogenesis of lower genital tract processes such as endocervicitis and cervical atypia. In a pilot study of appropriate treatment for patients with 
